AgomAb Therapeutics N.V. American Depositary (AGMB) Earnings Analysis
AgomAb Therapeutics N.V. American Depositary (AGMB) next reports earnings on 2026-07-23, consensus EPS -0.38461 USD. Last quarter (2026-06-03) it beat with EPS -0.42171 USD vs -0.42204 USD est (+0.1%). It has beaten estimates in 1/2 recent quarters (50%). Trailing P/E -8.26.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does AGMB next report earnings?
| Next earnings date | 2026-07-23 |
|---|---|
| Consensus EPS estimate | -0.38461 USD |
| Revenue estimate | n/a |
AGMB earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-06-03 | -0.42171 USD | -0.42204 USD | +0.1% | Beat |
| 2026-04-23 | -45.68844 USD | -0.51678 USD | -8741% | Miss |
Beat rate: 1/2 (50%) over reported quarters with consensus data.
AGMB valuation and analyst view
| Trailing P/E | -8.26 |
|---|---|
| Trailing EPS | -1.23271 USD |
| Price / book | 3.78 |
| Dividend yield | 0.00% |
| Market cap | 0.58B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is AgomAb Therapeutics N.V. American Depositary (AGMB)'s next earnings date?
AgomAb Therapeutics N.V. American Depositary is next scheduled to report on 2026-07-23, with a consensus EPS estimate of -0.38461 USD.
Did AGMB beat earnings last quarter?
In its 2026-06-03 report, AGMB posted EPS of -0.42171 USD versus a -0.42204 USD estimate — a beat of 0.1%.
What is AGMB's earnings track record?
Over the last 2 reported quarters with consensus data, AGMB beat estimates 1 times (50%).
What is AGMB's current P/E ratio and EPS?
AGMB trades at a trailing P/E of -8.26 on trailing EPS of -1.2327125270219437 USD.
What do analysts rate AGMB?
AGMB has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.